Author Correction: Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis

Key Points

• Sensitive detection of tumor mutations in blood enhances prognosis for immunotherapy.
• A key finding indicates that utilizing blood biomarkers improves clinical outcomes for cancer patients.
• Assessment of tumor mutations involved advanced detection methods and blood analysis.
• This approach highlights the importance of non-invasive methods for cancer treatment planning.